Jack Carr | Health Professions | Best Researcher Award

Mr. Jack Carr | Health Professions | Best Researcher Award

Coventry University | United Kingdom

Mr. Jack Carr is a dedicated researcher at the University of Northumbria, Newcastle, United Kingdom, with expertise spanning exercise physiology, cardiovascular health, cancer research, and health inequalities. His multidisciplinary work integrates biomedical science and public health, exploring how physiological and genomic factors shape disease outcomes across diverse populations. He has published in reputed journals such as PLOS One, Experimental Physiology, Progress in Cardiovascular Diseases, Heart and Mind, and Cancer Medicine. His studies address critical issues including post-COVID-19 recovery, neurophysiological measurement reliability, cultural disparities in physical activity, and ethnic genomic variations in cancer. With 4 publications, 4 citations, and an h-index of 1, Mr. Jack Carr represents a promising early-career researcher contributing to the advancement of translational and community-centered health science.

Profile: Scopus | Orcid

Featured Publications

Carr, J., Faghy, M. A., Broom, D., & Ashton, R. E. M. (2025). Investigating genomic differences by ethnicity in breast, colorectal and prostate cancers: Secondary data analysis of the Genomic Data Commons (GDC) database. Cancer Medicine.

Brownson-Smith, R., Mengarelli, A., Carr, J., Fox, K. T., Orange, S. T., Cresti, N., Saxton, J., & Temesi, J. (2025). The test-retest reliability of the H-reflex and swaymeter in women aged 30–65 years. PLOS One.

Thomas, C., Kudiersky, N., Ansdell, P., Ashton, R. E., Brown, C., Bewick, T., Carr, J., Hume, E., Spillane, P., & Pastorio, E. (2025). Submaximal 2-day cardiopulmonary exercise testing to assess exercise capacity and post-exertional symptom exacerbation in people with long COVID. Experimental Physiology.

Faghy, M. A., Carr, J., Broom, D., Mortimore, G., Sorice, V., Owen, R., Arena, R., & Ashton, R. E. M. (2025). The inclusion and consideration of cultural differences and health inequalities in physical activity behaviour in the UK: The impact of guidelines and initiatives. Progress in Cardiovascular Diseases.

Faghy, M. A., Carr, J., Broom, D. R., Owen, R., & Ashton, R. E. (2025). Cardiovascular disease in the post-COVID-19 era: A narrative review on the impact of lifestyle behaviors. Heart and Mind.

Victor Wallis | Public Health | Best Researcher Award

Prof. Victor Wallis | Public Health | Best Researcher Award

Berklee College of Music | United States

Prof. Victor Wallis, from Berklee College of Music, Boston, United States, is a distinguished researcher specializing in social theory, political economy, and public health. His work critically examines capitalism, socialism, and policy formation, addressing contemporary societal challenges, including the impact of COVID-19 on governance and social structures. With 72 scholarly publications, including open-access articles such as Covid-19 in the History of Capitalism and The Impact of Censorship on COVID-19 Policy Formation in the United States, alongside book chapters in respected outlets like Monthly Review and Socialism and Democracy, Prof. Victor Wallis demonstrates a strong and diverse research portfolio. His scholarship has been cited 203 times across 163 documents, with an h-index of 8, reflecting significant influence and academic recognition. Collaborating with 14 co-authors, his contributions bridge rigorous academic inquiry and social critique, highlighting his relevance and impact in contemporary research, making him a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

  • Wallis, V. (2025). Covid-19 in the history of capitalism. Capitalism Nature Socialism.

  • Wallis, V. (n.d.). Limits to growth

  • Wallis, V. (n.d.). Katsiaficas, George

  • Wallis, V. (n.d.). Monthly Review

  • Wallis, V. (n.d.). Zeitlin, Maurice

  • Wallis, V. (n.d.). Socialism and Democracy

  • Wallis, V. (n.d.). The Impact of Censorship on COVID-19 Policy Formation in the United States

 

Sémah Tagougui | Exercise | Best Researcher Award

Dr. Sémah Tagougui | Exercise | Best Researcher Award

Dr. Sémah Tagougui at University of Lille, France

Dr. Sémah Tagougui is a University Lecturer at the University of Lille  and an internationally recognized researcher in exercise physiology, type 1 diabetes, and metabolic health 🧠. With a Ph.D. in Life Sciences and postdoctoral training in Brussels and Montreal , he leads innovative projects on glycemic control, including AI-based tools  and insulin technologies. He has secured competitive grants , published high-impact research 📚, and regularly speaks at global conferences. Honored with the RIPEC Award for Scientific Excellence 🏅, Dr. Tagougui’s work bridges clinical science and real-world application for chronic disease management 🩺.

Publication Profile

Orcid

Scopus

Google Scholar

Academic Background

Dr. Sémah Tagougui holds a Ph.D. in Life Sciences from the University of Lille , where his research focused on muscle and cerebral oxygenation in individuals with type 1 diabetes 💉. He also earned a Master’s degree in Adapted Physical Activities and Health from the same university 🏃‍♂️🩺. He completed two prestigious postdoctoral fellowships—one in Brussels  and another at the Institute of Clinical Research in Montreal . In 2022, he received his Habilitation to Supervise Research, a mark of academic excellence 🏅. His educational path reflects a strong commitment to clinical and physiological research 📚.

Professional Experience

Dr. Sémah Tagougui is currently serving as a University Lecturer at the University of Lille , where he has been actively teaching and conducting research since 2019 📚. He previously held roles as an ATER and doctoral tutor at the same university, shaping future professionals in sports science and health 🧠. His international experience includes postdoctoral research positions in Brussels  and Montreal , focusing on diabetes, exercise physiology, and metabolic health 💉. Dr. Tagougui also plays key roles in international collaborative projects , thesis committees , and scientific advisory panels, demonstrating leadership in academic and clinical research 🔬🩺.

Awards and Honors

Dr. Sémah Tagougui has received several prestigious awards in recognition of his outstanding contributions to science and health research 💉. In 2023, he was honored with the RIPEC Award for Scientific Excellence by the French National Council of Universities 🎖️. He also secured multiple competitive grants, including the Young Francophone Researcher Grant and the FRM Research Hope Grant 📑. His invited speaker roles at renowned institutions and conferences 🌍 further highlight his influence in the field. These accolades reflect his dedication to advancing knowledge in type 1 diabetes, exercise science, and metabolic health 🔬.

Research Focus

Dr. Sémah Tagougui’s research centers on the intersection of type 1 diabetes, exercise physiology, and metabolic health 💉. His work explores how physical activity impacts glycemic control, muscle oxygenation, and cerebral function in individuals with diabetes . He is actively developing AI-powered tools for personalized blood glucose prediction  and has contributed to cutting-edge studies on insulin technologies, artificial pancreas systems, and exercise-induced glucose fluctuations 🧬. Collaborating internationally , his goal is to transform exercise from a risk factor into a therapeutic strategy for diabetes management 🌍. His research has real-world clinical impact and global relevance 🌐📚.

Publication Top Notes

Acute cocoa flavanol improves cerebral oxygenation without enhancing executive function at rest or after exercise
📅 Year: 2016 | 🔢 Cited by: 68

The benefits and limits of technological advances in glucose management around physical activity in patients with type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 62

Muscle oxygen supply impairment during exercise in poorly controlled type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 62

Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives
📅 Year: 2019 | 🔢 Cited by: 52

Aerobic fitness influences cerebral oxygenation response to maximal exercise in healthy subjects
📅 Year: 2015 | 🔢 Cited by: 38

A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes
📅 Year: 2020 | 🔢 Cited by: 35

Muscle oxygen supply and use in type 1 diabetes: is there a limiting step?
📅 Year: 2020 | 🔢 Cited by: 33

Barriers to physical activity in children and adults living with type 1 diabetes: a complex link with real-life glycemic excursions
📅 Year: 2023 | 🔢 Cited by: 31

Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum during moderate intensity exercise in type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 27

Regional cerebral hemodynamic response to incremental exercise is blunted in poorly controlled patients with uncomplicated type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 22

Minimizing risk of exercise-induced glucose fluctuations in type 1 diabetes using insulin infusion: overview of strategies
📅 Year: 2021 | 🔢 Cited by: 19

Effectiveness of Ramadan fasting and concurrent training in obesity management: is the combination worth the weight?
📅 Year: 2023 | 🔢 Cited by: 18

Conclusion

Dr. Sémah Tagougui is an outstanding candidate for the Best Researcher Award due to his exemplary academic background, including a distinguished Ph.D. and postdoctoral fellowships, along with his habilitation to supervise research, demonstrating senior scientific leadership. As a University Lecturer at the University of Lille, he has led numerous competitive international grants and acted as Principal Investigator on innovative projects bridging exercise physiology and diabetes management. His high-impact publications in top journals and extensive citations reflect significant contributions to the field. Dr. Tagougui’s strong international collaborations, invited speaker roles, and translational focus on improving clinical outcomes highlight his sustained excellence, making him highly deserving of this honor.

 

 

Barsha Gadapani Pathak | Public Health | Women Researcher Award

Dr. Barsha Gadapani Pathak | Public Health | Women Researcher Award

Dr. Barsha Gadapani Pathak, University of Bergen and Society for Applied Studies, India

Dr. Barsha Gadapani Pathak is an Indian physician-scientist specializing in public health and implementation science, with a focus on maternal and child health. She is currently pursuing her Ph.D. at the University of Bergen, Norway, and serves as a Scientist at the Society for Applied Studies, New Delhi. With extensive experience in research, policy engagement, and program implementation, she has led and contributed to multiple WHO- and ICMR-funded projects. Her work spans childhood pneumonia, stillbirth prevention, anemia reduction, and kangaroo mother care. She is also a Lancet Citizens’ Commission Fellow and an invited expert for national and international public health forums. 🌍📊👩‍⚕️

Publication Profile

Google Scholar

🎓 Education

Dr. Pathak is currently pursuing a Ph.D. in Public Health with a specialization in Implementation Science and Maternal-Child Health at the University of Bergen, Norway. She holds a Diploma in Community Mental Health from Rajendra Institute of Medical Sciences, Ranchi (2021), and an MD in Community Medicine from Seth GS Medical College & KEM Hospital, Mumbai (2019), where she ranked 3rd in the university. She earned her MBBS from BVP, Pune University in 2013. Her educational background integrates clinical knowledge with public health expertise, providing a strong foundation for her implementation research in health system strengthening. 🎓📚🩺

💼 Experience

Dr. Pathak currently serves as a Scientist at the Society for Applied Studies, New Delhi, since September 2024. Previously, she was a Research Scientist and Young Investigator with PRERNA from 2020 to 2024. She also worked as an Assistant Professor in Community Medicine at KEM Hospital, Mumbai, and as a Medical Officer with the National Health Mission, Assam. With over a decade of cross-disciplinary experience in academia, clinical settings, and global health research, she has contributed extensively to national health programs and WHO guideline development efforts, bridging field implementation with evidence-based policy making. 🧪🏥🌐

🏅 Awards and Honors

Dr. Pathak has received numerous accolades, including the Best Resident Award from the Municipal Corporation of Greater Mumbai (2019) and the Parimala Subramaniyan Award for excellence in Community Medicine (2018). She ranked 3rd in MD Community Medicine at the Maharashtra University of Health Sciences and earned a Certificate of Appreciation at an International Public Health Conference (2020). She has secured multiple prestigious grants from WHO, ICMR, and DJST, and has served as a speaker, expert panelist, and resource person in national and global forums, highlighting her dedication and leadership in advancing public health. 🏆🎖️📜

🔬 Research Focus

Dr. Pathak’s research focuses on implementation science in maternal and child health, particularly improving healthcare delivery for childhood pneumonia, stillbirth prevention, neonatal care (iKMC), and anemia control. She leads and collaborates on WHO- and ICMR-funded projects aimed at translating evidence into scalable health system interventions. Her work combines mixed-methods research with health systems strengthening to reduce mortality and improve care coverage. Additionally, she has contributed to national guidelines and global evidence syntheses on childhood pneumonia and low-birth-weight care. Her studies are impactful, policy-relevant, and grounded in community-based participatory approaches. 👶📈📑

Publication Top Notes

  • Effects of kangaroo mother care on maternal and paternal health: systematic review and meta-analysis – BG Pathak, B Sinha, N Sharma, S Mazumder, N Bhandari 🍼👶 – Cited by 402023

  • Obesity prevalence and determinants among young adults, with special focus on normal-weight obesity; a cross-sectional study in Mumbai – RS Hadaye, RM Manapurath, BP Gadapani 🍔⚖️ – Cited by 332020

  • Body composition of infants born with intrauterine growth restriction: a systematic review and meta-analysis – R Manapurath, B Gadapani, L Pereira-da-Silva 🍼📉 – Cited by 272022

  • Nutritional status of the student nurses of a tertiary health-care center–a mixed-method study – R Hadaye, B Pathak, S Lavangare 🥗💉 – Cited by 182019

  • Enteral low-dose vitamin A supplementation in preterm or low birth weight infants to prevent morbidity and mortality: a systematic review and meta-analysis – RM Manapurath, M Kumar, BG Pathak, R Chowdhury, B Sinha, … 💊🍼 – Cited by 142022

  • Mixed-method analysis of community health camps: A novel approach beckoning – A Bhondve, B Pathak, RM Manapurath 🏥👥 – Cited by 142019

  • Normal weight obesity: role of apoB and insulin sensitivity in predicting future cardiovascular risk – RM Manapurath, R Hadaye, B Gadapani 💔💉 – Cited by 82022

  • Awareness and acceptance of H1N1 vaccination among physicians: Experience of 2017 vaccination campaign – RS Hadaye, RM Manapurath, BP Gadapani 💉🦠 – Cited by 62019

  • Combating the pandemic of COVID-19 in India: Health care worker perspective – RMM Barsha Gadapani 🦠🏥 – Cited by 52020

  • Noncompliance of the postexposure prophylactic vaccination following animal bites reporting to a rural primary health center – RMM Barsha Gadapani, Rahini S 🐕💉 – Cited by 52019

  • Diet and lifestyle risk factors associated with young adult hypertensives in India–Analysis of National Family Health Survey IV – RM Manapurath, RM Anto, B Pathak, S Malhotra, P Khanna, S Goel 🥦🍔 – Cited by 42022

  • Analyzing the challenges and demotivating factors faced by accredited social health activist workers in tribal India in implementing their roles – RMM Swati Deshpande, Barsha Gadapani P 🏞️💪 – Cited by 42019

  • Tobacco smoking and blood pressure: How are they related among the Indians?–A secondary analysis of National Family Health Survey (NFHS)-4 data – BG Pathak, S Rahini, RM Manapurath, BN Sharath, R Gupta, S Goel 🚬💉 – Cited by 32022

  • Utilizing “Positive deviance inquiry” to explore factors influencing child health: A qualitative study – R Sabale, BG Pathak, RM Manapurath 🧒🩺 – Cited by 32021

  • Catalyzing healthcare accessibility through cashless payment gateways in India: a digital revolution – BG Pathak, G Mathew, V Chandru, MS Kamath 💳🏥 – Cited by 22024

Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Dr. Kidanu Hurisa Chachu | Public Health | Best Researcher Award

Dr. Kidanu Hurisa Chachu,Network of Networks of HIV Positives in Ethiopia (NEP+), Ethiopia

Dr. Kidanu Hurisa Chachu is a seasoned Senior Public Health Specialist with over 16 years of extensive experience in the field. With a PhD in Public Health and advanced degrees in the same discipline, he has demonstrated leadership in managing national programs in HIV, TB, immunization, and environmental health. Currently serving as the Program Director at NEP+, he oversees strategic implementation across 300+ health facilities, coordinating community-based HIV care and psychosocial support. Previously, he served as a Technical Officer at UNDP, where he strengthened health and environment programs at the national level. His core strengths include project coordination, M&E, stakeholder engagement, data management, and advocacy. Dr. Kidanu is multilingual, fluent in English, Afan Oromo, and Amharic. His career is marked by data-driven decision-making, community impact, and successful partnerships with international donors, such as the Global Fund, UNAIDS, and PEPFAR.

Publication Profile

Google Scholar

🎓 Education

Dr. Kidanu holds a Doctor of Philosophy in Public Health from the University of South Africa (UNISA), where he is finalizing his doctoral research. His academic journey began with a Bachelor of Science in Public Health from Haramaya University in Ethiopia, completed in 2008. Driven by a passion for community health, he further pursued his Master’s degree in General Public Health from Wollega University, graduating in 2016. Throughout his academic path, Dr. Kidanu has focused on strengthening health systems, improving disease surveillance, and addressing public health challenges in resource-limited settings. His studies emphasize a strong foundation in research, statistical analysis, and results-based management, all of which are evident in his professional approach. His academic background has been essential to his leadership roles and to his ability to drive impactful, evidence-based public health interventions.

💼 Experience

Dr. Kidanu currently leads NEP+ as Program Director, overseeing HIV response strategies across Ethiopia. He manages over 600 adherence supporters and leads national initiatives like Community-Led Monitoring (CLM), economic empowerment, and mother support groups. Prior to NEP+, he served as Technical Officer at UNDP (2021–2024), providing strategic and technical guidance on health and environment programs. There, he collaborated with the Ministry of Health and Environmental Protection Authority to improve project outcomes, mobilize resources, and manage donor-funded initiatives. His earlier experience spans clinical practice, research, and M&E roles that focused on HIV, TB, immunization, and environmental health. Dr. Kidanu’s hands-on experience in fieldwork, stakeholder engagement, and donor coordination reflects his dedication to delivering sustainable public health outcomes and system strengthening across Ethiopia.

🏅 Awards and Honors

While specific awards are not explicitly listed, Dr. Kidanu’s career achievements reflect recognition at both national and international levels. At NEP+, he led the successful scale-up of key initiatives including Community-Led Monitoring and economic empowerment programs for PLHIV, achievements often recognized by partner institutions and donors. His leadership has enhanced Ethiopia’s HIV treatment adherence and digital M&E systems. At UNDP, his work contributed to policy development and was praised for aligning with SDG targets and donor expectations, particularly in collaboration with the EU and MoH. His consistent success in grant writing, program reporting, and stakeholder coordination underscores a highly commendable career. His track record suggests recognition through internal promotions, project expansions, and trusted leadership in donor-funded programs, affirming his status as a key figure in Ethiopia’s public health sector.

🔬 Research Focus

Dr. Kidanu’s research focus centers on health systems strengthening, monitoring and evaluation (M&E), and community-led HIV interventions. His doctoral work at UNISA contributes to the evidence base for improving adherence support, stigma reduction, and access to treatment in Ethiopia. His academic and field research explore the intersections of public health, environmental factors, and chronic disease management. He emphasizes participatory approaches, particularly Community-Led Monitoring (CLM), to generate real-time data and inform policy. Additionally, he’s contributed to studies involving maternal and child health, digital health systems, and the socio-economic empowerment of PLHIV. His evidence-driven strategies are reflected in national programs that integrate research findings into scalable interventions. His work contributes to global dialogues on sustainable HIV responses and health equity in low-resource settings.

Publication Top Notes

📘 Prevalence and Factors Associated with Current Cigarette Smoking among Ethiopian University Students: A Systematic Review and Meta‐AnalysisJournal of Addiction – Cited by: 21 – Year: 2020 🔍🚬📊
📘 Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in EthiopiaHIV Medicine – Cited by: 0 – Year: 2025 🧬📈👥
📘 Viral suppression among patients in HIV/AIDS care at healthcare facilities in Ethiopia: Same-day antiretroviral initiationPLOS ONE – Cited by: 0 – Year: 2025 💊📉🏥
📘 Retention of patients in HIV/AIDS care at the healthcare facility level in Ethiopia: Same-day antiretroviral initiation statusUnspecified Journal – Cited by: 0 – Year: 2024 🏥🔄🧪
📘 Same-day antiretroviral therapy initiation and its association with viral suppression and retention in HIV care in EthiopiaUniversity of South Africa (Thesis) – Cited by: 0 – Year: 2024 🎓📚📉
📘 Strategies for strengthening same-day ART initiation, tracing people living with HIV lost to follow-up and viral load monitoring mechanisms in EthiopiaHIV Medicine (duplicate) – Cited by: 0 – Year: 2025 🔁📊🧬

Pingping Cai | Medicine | Best Researcher Award

Dr. Pingping Cai | Medicine | Best Researcher Award

Professor at Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

Prof. Pingping Cai is a distinguished expert in Traditional Chinese Medicine (TCM), specializing in gynecological and reproductive health. She is a Professor at the Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China. With a Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine, her research focuses on TCM treatments for infertility, gynecological tumors, pregnancy disorders, breast diseases, and reproductive endocrine diseases. Prof. Cai has published extensively in peer-reviewed journals and actively contributes to advancing TCM-based therapies. Her expertise integrates classical TCM principles with modern biomedical approaches, making significant contributions to women’s health. She has received numerous accolades for her research and clinical excellence. 🌿🏥📚

Publication Top Notes

scopus

🎓 Education

Prof. Pingping Cai earned her Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine (2003-2006), where she focused on integrating classical Chinese medical theories with modern gynecological treatments. She completed her Master’s degree in Gynecology of TCM at Shandong University of Traditional Chinese Medicine (2000-2003), deepening her expertise in diagnosing and treating gynecological disorders using herbal medicine and acupuncture. Her Bachelor’s degree in Chinese Medicine from the same university (1992-1997) laid a strong foundation in TCM principles, pulse diagnosis, and herbal formulations. Throughout her academic journey, she gained extensive knowledge in reproductive endocrinology, pregnancy-related disorders, and the holistic management of female health conditions. Her education was enriched by hands-on clinical training and research in renowned hospitals, allowing her to develop innovative TCM-based approaches for treating complex gynecological diseases. Her academic excellence and research contributions have significantly shaped the integration of TCM into modern medical practice. 🎓📖🌱

💼 Experience

Since 2006, Prof. Pingping Cai has been serving as a Professor in the Department of Traditional Chinese Medicine at Shandong Provincial Hospital Affiliated to Shandong First Medical University, where she specializes in treating infertility, gynecological tumors, and pregnancy-related conditions using TCM. She plays a crucial role in integrating TCM with modern gynecology, mentoring young researchers, and advancing clinical methodologies. Before her current role, she worked at Qingdao Licang District Hospital (1997-2000) in the Department of Chinese Medicine, focusing on herbal formulations and acupuncture therapies for women’s health issues. Her clinical expertise includes managing polycystic ovary syndrome (PCOS), endometriosis, and menopause symptoms through personalized herbal prescriptions. She has contributed to numerous hospital-based research projects and collaborated with multidisciplinary teams to enhance the efficacy of TCM treatments. Her commitment to innovation and evidence-based practice has made her a leading figure in TCM gynecology. 🏥🌿👩‍⚕️

🏅 Awards & Honors

Prof. Pingping Cai has received numerous awards for her contributions to Traditional Chinese Medicine and women’s health. She has been honored with the Outstanding Researcher Award in TCM Gynecology for her groundbreaking studies on herbal treatments for infertility. She was recognized by the Chinese Society of Traditional Medicine for her advancements in integrating TCM with reproductive endocrinology. Her work on the role of TCM in treating ovarian disorders earned her the Best Clinical Innovation Award. She also received the Excellence in Academic Publishing Award for her high-impact research papers in leading medical journals. Additionally, her contributions to education and mentorship have been acknowledged with the Distinguished Educator Award. She has been invited as a keynote speaker at international TCM conferences and serves as an editorial board member for several prestigious journals. Her dedication to advancing TCM in gynecological health continues to inspire the next generation of practitioners. 🏆📜🌏

🔬 Research Focus

Prof. Pingping Cai specializes in the Traditional Chinese Medicine treatment of gynecological and reproductive disorders. Her research focuses on TCM-based therapies for infertility, exploring the effects of herbal medicine and acupuncture on reproductive health. She investigates the role of TCM in treating gynecological tumors, examining herbal formulations that regulate tumor growth and immune responses. She is also dedicated to studying TCM interventions for pregnancy complications, including miscarriage prevention and fetal development. Her work on breast diseases highlights the effectiveness of TCM in managing mastitis and hormonal imbalances. Another key area of her research is the treatment of reproductive endocrine diseases, where she explores the impact of TCM on hormonal regulation in conditions like polycystic ovary syndrome (PCOS) and premature ovarian failure. Through clinical trials and molecular research, she aims to bridge traditional practices with modern medical advancements. Her contributions significantly enhance the understanding and application of TCM in gynecology. 🌿🩺📊

 

Publication Top Notes

  • Xu Y, Li Y, Zhang J, Cai P. “Hua Yu Xiao Zheng decoction induces ectopic endometrial stromal cell senescence via inhibiting the PI3K/AKT signaling.” Tissue Cell. 2025 Apr;93:102763.

  • Shao W, Lin Z, Xiahou Z, Zhao F, Xu J, Liu X, Cai P. “Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.” Front Immunol. 2024 Jul 29;15:1438198.

  • Wang Y, Cai P, Qi F. “Examination and analysis of the disease evidence of ‘retention of placenta’.” China Journal of Basic Medicine in Traditional Chinese Medicine. 2024;30(10):1633-1637.

  • Wang Z, Cai P. “Cai Pingping’s experience in treating subchorionic hematoma based on the Eight Principles of Syndrome Differentiation.” Shanghai Journal of Traditional Chinese Medicine. 2024;58(04):54-57.

  • Yan R, He J, Xue Y, Wang Y, Dong R, Cai P. “Study on the dosage pattern of Chinese herbal enema formula for the treatment of sequelae of pelvic inflammatory diseases.” Chinese Traditional Patent Medicine. 2024;46(10):3492-3496.

  • Su N, Cai P, Dou Z, Yin X, Xu H, He J, Li Z, Li C. “Brain nuclei and neural circuits in neuropathic pain and brain modulation mechanisms of acupuncture: a review on animal-based experimental research.” Front Neurosci. 2023 Aug 30;17:1243231.

  • Wang Y, Qiu H, Yan R, Jing W, Li J, Cai P. “Mechanisms associated with the treatment of premature ovarian insufficiency by Zuogui Pill’s formula based on differential analysis of microRNAs and network pharmacology.” Chinese Archives of Traditional Chinese Medicine. 2023;41(04):81-86+269-273.

  • Wang Y, Yan R, Jing W, Cai P. “Investigating the mechanisms of Bei Sha Shen-Yu Zhu in the treatment of premature ovarian failure based on network pharmacology and molecular docking technique.” Traditional Chinese Drug Research and Clinical Pharmacology. 2022;33(05):645-654.

  • Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.” Biosci Trends. 2018;12(3):220-239.

  • Cai P, Liu X, Xu Y, Qi F, Si G. “Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.” Biosci Trends. 2017;11(6):640-650.

 

 

 

Sylvia Kusemererwa | Public Health | Best Researcher Award

Dr. Sylvia Kusemererwa | Public Health | Best Researcher Award

Dr. Sylvia Kusemererwa, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Uganda

Dr. Sylvia Kusemererwa is a distinguished Scientist A, Project Leader, and Principal Investigator at MRC/UVRI & LSHTM Uganda Research Unit. She holds an MBChB and MPH from Makerere University and has extensive experience in clinical research, epidemiology, and infectious disease management. Dr. Kusemererwa has led multiple clinical trials on HIV prevention, malaria vaccines, and COVID-19 research. She actively contributes to national health policies, serving as Chair of the Masaka Regional Referral Hospital Research Ethics Committee. Her work has significantly impacted public health in Uganda and beyond. 📍

Publication Profile

Orcid

🎓 Education

Dr. Kusemererwa earned her MBChB (2001) and MPH (2010) from Makerere University, equipping her with expertise in public health and clinical research. She pursued specialized training in project management (PRINCE2), global health leadership (Afya Bora Fellowship), and research ethics. She has completed advanced courses in statistics, epidemiology, and scientific manuscript writing. Her certifications include GCP from LSHTM and Citiprogram HSP. Her continuous learning reflects her dedication to high-quality clinical trials and ethical research governance. 📚

👩‍⚕️ Experience

Dr. Kusemererwa has held key positions, including Scientist A at MRC Uganda, Clinical Coordinator at TASO Mbale, and Medical Officer at Kampala Medical Chambers. She has been a Principal Investigator and Study Coordinator for numerous trials on HIV vaccines, COVID-19, and malaria. Her leadership in clinical research spans over two decades, significantly advancing Uganda’s infectious disease research landscape. She also mentors researchers and chairs ethics committees, ensuring adherence to international research standards. 🏥

🏆 Awards & Honors

Dr. Kusemererwa has been recognized for her contributions to public health and research ethics. She is Chair of the Masaka Regional Referral Hospital Research Ethics Committee and a mentor in the MRC-CTU Mentorship Scheme. She has received fellowships in global health leadership and numerous accolades for her role in advancing vaccine research and ethical clinical trials in Uganda. Her commitment to scientific excellence has established her as a leader in biomedical research. 🌍

🔬 Research Focus

Dr. Kusemererwa specializes in clinical trials for infectious diseases, focusing on HIV prevention, malaria vaccines, and emerging infections like COVID-19. She has led Phase 2 and 3 trials on HIV PrEP, vaccine efficacy, and maternal immunization. Her research emphasizes public health impact, implementation science, and ethical considerations in clinical studies. She collaborates globally to optimize vaccine deployment and improve healthcare interventions in sub-Saharan Africa. 🧪

Publication Top Notes

  • “Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda” (2021)

  • “Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda” (2022)

  • “Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis” (2024)

  • “Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda” (2023)

  • “Contraceptive Preference Among Women at Risk of HIV Acquisition in Southwestern Uganda” (2018)

 

 

Rutu Rathod | Public Health | Best Researcher Award

Dr. Rutu Rathod | Public Health | Best Researcher Award

Dr. Rutu Rathod, University of Arkansas for Medical Sciences, United States

🎓 Dr. Rutu A. Rathod, PhD, MPH, MBBS is an Assistant Professor of Epidemiology at the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, and a member of the Cancer Prevention and Population Sciences Program at the Winthrop P. Rockefeller Cancer Institute. She earned her PhD in Epidemiology from the University of Memphis, MPH from Texas A&M University, and MBBS from Sumandeep Vidyapeeth University, India. Dr. Rathod specializes in cancer epidemiology, DNA methylation, and health disparities. With numerous publications, honors, and funded research projects, she is advancing the understanding of social determinants of health and their impact on chronic diseases. 📊🌎

Publication Profile

Google Scholar

Academic Journey 🎓

Dr. Rutu Rathod is a dedicated public health professional with a strong academic foundation. She earned her Ph.D. in Epidemiology in 2021 from the University of Memphis, specializing in Biostatistics and Environmental Health Sciences. Prior to this, she completed her Master of Public Health (MPH) in Epidemiology in 2018 at Texas A&M University, gaining expertise in epidemiological research and biostatistical methods. Dr. Rathod began her academic journey with a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in 2015 from Sumandeep Vidyapeeth University, India, laying the groundwork for her career in healthcare and research. 🌍📊🔬

 

Professional Experiences

Dr. Rutu Rathod is an accomplished epidemiologist with diverse professional experiences. Currently, she serves as an Assistant Professor (Tenure-track) at the Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, and as a member of the Cancer Prevention and Population Sciences Program at the Winthrop P. Rockefeller Cancer Institute. She is also an Adjunct Assistant Professor at the University of Texas Southwestern Medical Center. Her prior roles include Graduate Research Assistantships, focusing on DNA methylation, asthma, obesity, and prenatal alcohol exposure, as well as clinical roles as a physician and intern in India. 🧬🩺📚

 

Honors and Awards

Dr. Rutu Rathod has received numerous accolades for her contributions to public health and academic research. She earned the prestigious Gold Medallion as a Public Health Scholar at Texas A&M University in 2018. At the University of Memphis, she was recognized with the Student Accomplishment Award (2021) and multiple travel awards (2019-2020). Dr. Rathod also secured second place at the 32nd Annual Student Research Forum (2020) in Life and Health Sciences and received the School of Public Health Student Achievement Award. Her dedication to research and excellence is further highlighted by awards from the Department of Neuroscience. 🎓🏆📊

 

Research Focus

Dr. Rutu Rathod’s research centers on the intersection of epigenetics and respiratory health. Her work explores how DNA methylation mediates the impact of early-life BMI trajectories on asthma and lung function in adulthood. She investigates sex-specific associations between asthma and epigenetic changes, the role of methylation in coronavirus-related gene expression, and chronic disease risk factors like myocardial infarction. Dr. Rathod contributes significantly to understanding gene-environment interactions and their effects on respiratory conditions, with a focus on using epigenetic markers for disease prediction and prevention. Her research bridges epidemiology and molecular biology. 📊🩺📖

 

Publication Top Notes

  • Sex‐specific associations of asthma acquisition with changes in DNA methylation during adolescence (29 citations, 2021) 📄🧬
  • BMI trajectory in childhood is associated with asthma incidence at young adulthood mediated by DNA methylation (18 citations, 2021) 📊🌬️
  • Methylation of host genes associated with coronavirus infection from birth to 26 years (9 citations, 2021) 🦠🧬
  • Association of childhood BMI trajectory with post-adolescent and adult lung function mediated by pre-adolescent DNA methylation (7 citations, 2022) 📈🌬️
  • Association of asthma and rhinitis with epigenetics of coronavirus-related genes (5 citations, 2021) 🤧🧬
  • BMI trajectory in childhood is associated with asthma incidence at young adulthood mediated by DNA methylation (1 citation, 2021) 📊🩺
  • Epidemiological Studies on Risk Factors of Chronic Diseases (No citations, 2021) 📘📊
  • Risk factors of myocardial infarction at later age in healthy middle-aged men (No citations, 2020) 🫀📊
  • The Association of Asthma Acquisition with DNA Methylation Changes During Adolescence Is Gender-Specific (No citations, 2020) 🧬👩‍⚕️
  • Association of BMI Trajectory in Earlier Childhood with Lung Function in Adulthood Mediated by DNA Methylation (No citations, 2020) 📈🌬️
  • BMI Trajectory in Childhood Associated with Asthma at Young Adulthood Mediated by DNA Methylation (No citations, 2019) 🧬📊

 

Chun-Feng Huang | Health Professions | Best Researcher Award

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilmLi, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infectionsYang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound HealingZhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effectorLin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathwaysShan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1αWang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious OsteomyelitisLe, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 UbiquitinationChen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger OsteomyelitisZhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptorWu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱